Skip to main content
. 2021 Jul 16;65(8):e00486-21. doi: 10.1128/AAC.00486-21

TABLE 1.

MIC distributions for 64 Enterobacterales isolates tested against ceftazidime-avibactam, aztreonam, and aztreonam-avibactam: AR Lab Network, March 2019 to December 2020

Isolate categories Antimicrobial agenta No. of isolates at each MIC (μg/ml) for each antimicrobial agentb
MIC50c MIC90c
≤0.03 0.06 0.12 0.25 0.5 1 2 4 8 16 32 64 >64
All (64) CZA 64 >64/4 >64/4
ATM 2 1 1 3 4 4 8 41 >64 >64
AZA 7 7 11 13 7 1 9 7 2 0.5/4 8/4
Escherichia coli (28) CZA 28 >64/4 >64/4
ATM 1 3 2 3 19 >64 >64
AZA 1 4 3 2 1 8 7 2 4/4 8/4
 NDM (27) CZA 27 >64/4 >64/4
ATM 1 3 2 3 18 >64 >64
AZA 1 4 3 2 1 8 6 2 4/4 8/4
 NDM & OXA-48-like (1) CZA 1
ATM 1
AZA 1
Klebsiella pneumoniae (24) CZA 24 >64/4 >64/4
ATM 1 1 5 17 >64 >64
AZA 3 2 8 8 2 1 0.25/4 1/4
 NDM (17) CZA 17 >64/4 >64/4
ATM 1 4 12 >64 >64
AZA 2 2 7 4 1 1 0.25/4 1/4
 NDM & OXA-48-like (7) CZA 7
ATM 1 1 5
AZA 1 1 4 1
Enterobacter cloacae complex, NDM (10) CZA 10 >64/4 >64/4
ATM 2 2 1 5 32 >64
AZA 2 1 3 1 3 0.25/4 1/4
Morganella morganii, NDM & KPC (1) CZA 1
ATM 1
AZA 1
Proteus mirabilis, NDM (1) CZA 1
ATM 1
AZA 1
a

ATM, aztreonam; AZA, aztreonam-avibactam; CZA, ceftazidime-avibactam. Avibactam is at a constant concentration of 4 μg/ml when in combination.

b

Gray shading indicates the not susceptible ranges for CZA and ATM. AZA does not have interpretive criteria.

c

MIC50 and MIC90 were calculated only for groups with >9 isolates.